Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 64
Filter
1.
J Med Case Rep ; 15(1): 595, 2021 Dec 15.
Article in English | MEDLINE | ID: mdl-34906240

ABSTRACT

BACKGROUND: Idiopathic pulmonary fibrosis is a disease with a poor prognosis and has been associated with increased lung cancer incidence. CASE PRESENTATION: We report the case of a Caucasian 75-year-old woman, a former smoker, hospitalized for breathlessness with a chest computed tomography scan showing an interstitial lung disease. A surgical lung biopsy was performed, confirming a pattern of usual interstitial pneumonia but also numerous disseminated foci of well-differentiated focally invasive squamous cell carcinoma without hypermetabolic lung nodule, mass, or enlarged lymph node visualized on chest computed tomography or positron emission tomography scan. Nintedanib was started for its antifibrotic and antitumor properties, without any other antineoplastic treatment. Three years after initiation of nintedanib, clinical, functional, and computed tomography scan evaluations were stable, and there was no evidence for evolution of the squamous cell carcinoma. CONCLUSIONS: Data are scarce regarding the benefit of nintedanib in patients with idiopathic pulmonary fibrosis-associated lung cancer, and it is unclear whether nintedanib could have a preventive role in lung carcinogenesis in idiopathic pulmonary fibrosis patients. This experience could help the scientific community in case of similar incidental findings.


Subject(s)
Carcinoma, Squamous Cell , Idiopathic Pulmonary Fibrosis , Lung Neoplasms , Aged , Biopsy , Carcinoma, Squamous Cell/complications , Epithelial Cells , Female , Humans , Idiopathic Pulmonary Fibrosis/complications , Idiopathic Pulmonary Fibrosis/diagnostic imaging , Idiopathic Pulmonary Fibrosis/drug therapy , Lung/diagnostic imaging
2.
J Pharmacol Exp Ther ; 365(2): 301-313, 2018 05.
Article in English | MEDLINE | ID: mdl-29491038

ABSTRACT

Methionine aminopeptidase 2 (MetAP2) inhibition is a promising approach to treating diabetes, obesity, and associated metabolic disorders. Beloranib, a MetAP2 inhibitor previously investigated for treatment of Prader-Willi syndrome, was associated with venous thrombotic adverse events likely resulting from drug effects on vascular endothelial cells (ECs). Here, we report the pharmacological characterization of ZGN-1061, a novel MetAP2 inhibitor being investigated for treatment of diabetes and obesity. Four weeks of subcutaneous administration of ZGN-1061 to diet-induced obese (DIO) insulin-resistant mice produced a 25% reduction in body weight, primarily due to reduced fat mass, that was comparable to beloranib. ZGN-1061 also produced improvements in metabolic parameters, including plasma glucose and insulin, and, in HepG2 cells, initiated gene changes similar to beloranib that support observed in vivo pharmacodynamics. In vitro studies in ECs demonstrated that ZGN-1061 effects on EC proliferation and coagulation proteins were greatly attenuated, or absent, relative to beloranib, due to lower intracellular drug concentrations, shorter half-life of inhibitor-bound MetAP2 complex, and reduced cellular enzyme inhibition. In dogs, ZGN-1061 was more rapidly absorbed and cleared, with a shorter half-life than beloranib. Unlike beloranib, ZGN-1061 did not increase coagulation markers in dogs, and ZGN-1061 had a greatly improved safety profile in rats relative to beloranib. In conclusion, ZGN-1061 and beloranib demonstrated similar efficacy in a mouse model of obesity, while ZGN-1061 had a markedly improved safety profile in multiple in vitro and in vivo models. The lower duration of exposure characteristic of ZGN-1061 is expected to provide a meaningfully enhanced clinical safety profile.


Subject(s)
Aminopeptidases/antagonists & inhibitors , Azetidines/adverse effects , Azetidines/pharmacology , Metalloendopeptidases/antagonists & inhibitors , Morpholines/adverse effects , Morpholines/pharmacology , Obesity/drug therapy , Safety , Animals , Azetidines/pharmacokinetics , Azetidines/therapeutic use , Blood Coagulation/drug effects , Cinnamates/pharmacokinetics , Cinnamates/pharmacology , Cyclohexanes/pharmacokinetics , Cyclohexanes/pharmacology , Dogs , Enzyme Inhibitors/adverse effects , Enzyme Inhibitors/pharmacokinetics , Enzyme Inhibitors/pharmacology , Enzyme Inhibitors/therapeutic use , Epoxy Compounds/pharmacokinetics , Epoxy Compounds/pharmacology , Female , Hep G2 Cells , Humans , Hypoglycemic Agents/adverse effects , Hypoglycemic Agents/pharmacokinetics , Hypoglycemic Agents/pharmacology , Hypoglycemic Agents/therapeutic use , Male , Mice , Mice, Inbred C57BL , Morpholines/pharmacokinetics , Morpholines/therapeutic use , Obesity/enzymology , Rats , Sesquiterpenes/pharmacokinetics , Sesquiterpenes/pharmacology , Tissue Distribution
3.
Acta Clin Belg ; 69(3): 183-90, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24761948

ABSTRACT

OBJECTIVES: Guidelines for diagnosis of infective endocarditis are largely based upon epidemiological studies in referral hospitals. Referral bias, however, might impair the validity of guidelines in non-referral hospitals. Recent studies in non-referral care centres on infective endocarditis are sparse. We conducted a retrospective epidemiological study on infective endocarditis in a large non-referral hospital in a Belgian city (Kortrijk). METHODS: The medical record system was searched for all cases tagged with a putative diagnosis of infective endocarditis in the period 2003-2010. The cases that fulfilled the modified Duke criteria for probable or definite infective endocarditis were included. RESULTS: Compared to referral centres, an older population with infective endocarditis, and fewer predisposing cardiac factors and catheter-related infective endocarditis is seen in our population. Our patients have fewer prosthetic valve endocarditis as well as fewer staphylococcal endocarditis. Our patients undergo less surgery, although mortality rate seems to be highly comparable with referral centres, with nosocomial infective endocarditis as an independent predictor of mortality. CONCLUSION: The present study suggests that characteristics of infective endocarditis as well as associative factors might differ among non-referral hospitals and referral hospitals.


Subject(s)
Endocarditis/epidemiology , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Belgium , Endocarditis/microbiology , Endocarditis/therapy , Female , Hospitals, Community/statistics & numerical data , Hospitals, Urban/statistics & numerical data , Humans , Male , Middle Aged , Referral and Consultation , Retrospective Studies , Risk Factors , Treatment Outcome
4.
Respir Res ; 11: 81, 2010 Jun 21.
Article in English | MEDLINE | ID: mdl-20565920

ABSTRACT

BACKGROUND: Generalized hypoxic pulmonary vasoconstriction (HPV) occurring during exposure to hypoxia is a detrimental process resulting in an increase in lung vascular resistance. Nebulization of sodium nitrite has been shown to inhibit HPV. The aim of this project was to investigate and compare the effects of nebulization of nitrite and different formulations of acidified sodium nitrite on acute HPV. METHODS: Ex vivo isolated rabbit lungs perfused with erythrocytes in Krebs-Henseleit buffer (adjusted to 10% hematocrit) and in vivo anesthetized catheterized rabbits were challenged with periods of hypoxic ventilation alternating with periods of normoxic ventilation. After baseline hypoxic challenges, vehicle, sodium nitrite or acidified sodium nitrite was delivered via nebulization. In the ex vivo model, pulmonary arterial pressure and nitric oxide concentrations in exhaled gas were monitored. Nitrite and nitrite/nitrate were measured in samples of perfusion buffer. Pulmonary arterial pressure, systemic arterial pressure, cardiac output and blood gases were monitored in the in vivo model. RESULTS: In the ex vivo model, nitrite nebulization attenuated HPV and increased nitric oxide concentrations in exhaled gas and nitrite concentrations in the perfusate. The acidified forms of sodium nitrite induced higher levels of nitric oxide in exhaled gas and had longer vasodilating effects compared to nitrite alone. All nitrite formulations increased concentrations of circulating nitrite to the same degree. In the in vivo model, inhaled nitrite inhibited HPV, while pulmonary arterial pressure, cardiac output and blood gases were not affected. All nitrite formulations had similar potency to inhibit HPV. The tested concentration of appeared tolerable. CONCLUSION: Nitrite alone and in acidified forms effectively and similarly attenuates HPV. However, acidified nitrite formulations induce a more pronounced increase in nitric oxide exhalation.


Subject(s)
Hypoxia/drug therapy , Pulmonary Artery/drug effects , Sodium Nitrite/administration & dosage , Vasoconstriction/drug effects , Vasodilator Agents/administration & dosage , Acute Disease , Administration, Inhalation , Animals , Blood Pressure/drug effects , Cardiac Output/drug effects , Chemistry, Pharmaceutical , Disease Models, Animal , Dose-Response Relationship, Drug , Exhalation , Hydrogen-Ion Concentration , Hypoxia/physiopathology , Male , Nebulizers and Vaporizers , Nitrates/blood , Nitric Oxide/metabolism , Perfusion , Pulmonary Artery/physiopathology , Rabbits , Time Factors
5.
Arch Virol ; 154(8): 1285-91, 2009.
Article in English | MEDLINE | ID: mdl-19585076

ABSTRACT

Sera from 15 patients coinfected with TTV and HIV-1, collected before and at two times after introduction of highly active anti-retroviral therapy (HAART), were tested for TTV load and the presence of the five highly divergent TTV phylogenetic groups. Seven patients showed a 1-5 log TTV load decrease during HAART, while the others did not show significant variations. A decrease in the number of coinfecting TTV genogroups was detected in 12 of 15 patients, with the mean number of TTV genogroups/patient decreasing from 2.33 before HAART to 1.47 at the last collect. All five genogroups were less frequently found after introduction of HAART. Three hundred sixty-seven TTV clones from four different genogroups, derived from two patients, were sequenced. Noticeable fluctuations in TTV subpopulation frequencies were observed in both patients analyzed. In conclusion, HAART tends to reduce the number of TTV genotypes/genogroups and may affect the balance between different TTV isolates coinfecting single individuals.


Subject(s)
Anti-HIV Agents/therapeutic use , DNA Virus Infections/complications , DNA Virus Infections/virology , HIV Infections/blood , HIV Infections/complications , HIV-1 , Torque teno virus/isolation & purification , Adult , Antiretroviral Therapy, Highly Active , Brazil , DNA Virus Infections/blood , DNA, Viral/blood , Female , HIV Infections/drug therapy , Humans , Middle Aged , Torque teno virus/classification , Torque teno virus/genetics , Viral Load
6.
Arch Virol ; 153(12): 2197-205, 2008.
Article in English | MEDLINE | ID: mdl-18998047

ABSTRACT

This study was conducted in an Afro-Brazilian, slave-descendant community with high (42.4%) hepatitis B virus (HBV) prevalence. Twenty (8.4%) out of the 239 subjects under study were HBsAg-positive, and HBV-DNA was detected in 59 (25%) individuals. A high rate (18.3%) of occult infection was therefore observed that was associated to low HBV loads (mean, 1.8 x 10(4) copies/ml) and to a specific amino acid substitution (C100Y) in the small surface antigen. Genotyping of 50 isolates showed that 43 (86%) were of subgenotype A1, one (2%) from subgenotype A2, and five (10%) from subgenotype D. Mixed genotypes A1 and E were observed in one (2%) sample. The genetic distance (0.8 +/- 0.3%) among the HBV/A1 isolates from the community was smaller than the intragroup divergence among A1 isolates from Brazil as a whole, but it was similar to that found between A2 isolates from different countries, suggesting that HBV/A1 was introduced in the community through different sources. The substitution W501R (polymerase), previously reported only in Gambia, was observed in 46% of the HBV/A1 isolates. The precore/core promoter region of HBsAg-positive isolates showed several substitutions that could explain the anti-HBe phenotype found in 18 of 20 (90%) of the HBsAg-positive subjects.


Subject(s)
Hepatitis B virus/classification , Hepatitis B/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Base Sequence , Brazil/epidemiology , Child , Child, Preschool , Female , Genotype , Hepatitis B/immunology , Hepatitis B/virology , Hepatitis B Surface Antigens/genetics , Hepatitis B Surface Antigens/immunology , Hepatitis B virus/genetics , Hepatitis B virus/immunology , Hepatitis B virus/isolation & purification , Humans , Male , Middle Aged , Molecular Epidemiology , Molecular Sequence Data , Phylogeny , Prevalence , Young Adult
7.
J Appl Microbiol ; 105(1): 51-8, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18217932

ABSTRACT

AIMS: Torque teno virus (TTV) is a human DNA virus chronically infecting most healthy individuals worldwide and can be transmitted by faecal-oral route. The occurrence of TTV was evaluated in the streams crossing the city of Manaus (Brazilian Amazon) over a 1-year period, four times a year. METHODS AND RESULTS: Fifty-two water samples were collected from 13 different locations. Viruses were concentrated from two litres of water by adsorption to negative membrane filters followed by ultrafiltration. TTV DNA was detected by PCR assays designed to detect all five TTV genomic groups. By conventional PCR, 19/52 (37%) samples were positive. By real-time PCR, TTV DNA could be detected in 48/52 (92%) samples. Viral loads ranged from 1300 to 746 000 genome equivalent per 100 ml of river water. Eleven distinct nucleotide sequences were obtained. CONCLUSIONS: Our results show the wide distribution and diversity of TTV among Manaus urban micro basins. SIGNIFICANCE AND IMPACT OF THE STUDY: The data presented here may contribute to substantiate TTV as a sensitive indicator of human contamination.


Subject(s)
DNA, Viral/analysis , Torque teno virus/genetics , Urban Health , Water Microbiology , Base Sequence , Brazil , DNA Primers/genetics , Feces/microbiology , Humans , Molecular Sequence Data , Polymerase Chain Reaction/methods , Rivers , Water Supply
8.
Liver Transpl ; 13(3): 361-6, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17318854

ABSTRACT

This study examined the efficacy of the caspase inhibitor, IDN-6556, in a rat model of liver ischemia-reperfusion injury. Livers from male Sprague-Dawley rats were reperfused for 120 minutes after 24 hours of 4 degrees C cold storage in University of Wisconsin solution. Portal blood flow measurements estimated sinusoidal resistance, and bile production, alanine aminotransferase activities, and Suzuki scores were evaluated as parameters of hepatocyte/liver injury. Treated livers were exposed to 25 or 50 microM of IDN-6556 in University of Wisconsin storage solution and/or the perfusate. All treatment regimens with IDN-6556 significantly improved portal blood flow measured at 120 minutes, and significant improvements were seen as early as 30 minutes when inhibitor was also present in the perfusate (P < 0.01). All treatment groups with IDN-6556 significantly increased bile production by 3-4-fold compared with controls (P < 0.01), and reductions in alanine aminotransferase activities were seen within 90 minutes of reperfusion (P < 0.05). These data were confirmed by improved Suzuki scores (less sinusoidal congestion, necrosis, and vacuolization) in all treated groups. Livers from the IDN-6556-treated groups had markedly reduced caspase activities and TUNEL (terminal deoxynucleotidyl transferase dUTP nick-end labeling)-positive cells, suggesting reductions in apoptosis. IDN-6556 present in cold storage media ameliorated liver injury due to cold ischemia and reperfusion injury and may be a rational therapeutic approach to reduce the risk of liver ischemia in the clinical setting.


Subject(s)
Caspase Inhibitors , Enzyme Inhibitors/pharmacology , Pentanoic Acids/pharmacology , Reperfusion Injury/prevention & control , Temperature , Animals , Apoptosis/drug effects , Male , Models, Animal , Organ Preservation/methods , Organ Preservation Solutions/pharmacology , Rats , Rats, Sprague-Dawley , Reperfusion Injury/pathology , Treatment Outcome
9.
J Med Chem ; 48(22): 6779-82, 2005 Nov 03.
Article in English | MEDLINE | ID: mdl-16250635

ABSTRACT

A series of oxamyl dipeptides were optimized for pan caspase inhibition, anti-apoptotic cellular activity and in vivo efficacy. This structure-activity relationship study focused on the P4 oxamides and warhead moieties. Primarily on the basis of in vitro data, inhibitors were selected for study in a murine model of alpha-Fas-induced liver injury. IDN-6556 (1) was further profiled in additional in vivo models and pharmacokinetic studies. This first-in-class caspase inhibitor is now the subject of two Phase II clinical trials, evaluating its safety and efficacy for use in liver disease.


Subject(s)
Caspase Inhibitors , Liver Diseases/drug therapy , Pentanoic Acids/chemical synthesis , Adult , Alanine Transaminase/blood , Animals , Apoptosis/drug effects , Aspartate Aminotransferases/blood , Biological Availability , Caspase 3 , Cholestasis/drug therapy , Cholestasis/pathology , Clinical Trials, Phase I as Topic , Half-Life , Hepatitis C, Chronic/drug therapy , Hepatocytes/drug effects , Hepatocytes/pathology , Humans , Jurkat Cells , Liver/drug effects , Liver/pathology , Liver Diseases/enzymology , Liver Diseases/etiology , Mice , Pentanoic Acids/chemistry , Pentanoic Acids/pharmacology , Rats , Structure-Activity Relationship
10.
J Infect ; 51(1): 24-9, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15979486

ABSTRACT

OBJECTIVE: The aim of this study was to determine the rate of occult hepatitis B virus (HBV) infection among blood donors living in a geographic region of low (5.6%) anti-HBc prevalence. SUBJECTS AND METHODS: Sera from 150 candidate blood donors whose blood was rejected due to total anti-HBc reactivity (despite absence of HBsAg) were tested for anti-HBs and IgM anti-HBc antibodies, as well as for HBeAg/anti-HBe. Serum HBV DNA was sought by using a PCR assay able to amplify part of the surface gene. Viral load was measured in the PCR positive samples. RESULTS: The pattern 'anti-HBc alone' (without HBsAg and anti-HBs antibodies) was found in 64 (42.7%) subjects. IgM anti-HBc and anti-HBe antibodies were detected in 2 (1.3%) and 80 (53.3%) samples, respectively. No sample was HBeAg-reactive. HBV DNA was repeatedly found in five (3.3%) samples, three of which were anti-HBs positive and two anti-HBs negative. All five HBV DNA positive samples showed a low viral load (<1000copies/ml). CONCLUSIONS: The data indicated a low rate of occult infection among anti-HBc positive, HBsAg negative blood donors living in a region of low prevalence of infection. Viral load was very low in all HBV infected subjects.


Subject(s)
Blood Donors , Hepatitis B Antibodies/blood , Hepatitis B/epidemiology , Adult , Brazil/epidemiology , DNA, Viral/blood , Female , Hepatitis B Core Antigens/immunology , Humans , Male , Middle Aged , Prevalence , Viral Load
11.
Braz J Med Biol Res ; 38(6): 853-60, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15933778

ABSTRACT

Torque teno virus (TTV) is a circular, single-stranded DNA virus that chronically infects healthy individuals of all ages worldwide. TTV has an extreme genetic heterogeneity which is reflected in its current classification into five main phylogenetic groups (1-5). Using specific PCR assays, it has been shown that many individuals are co-infected with TTV isolates belonging to different phylogenetic groups. Here, a multiplex PCR assay was developed, using five recombinant plasmids. Each plasmid carried an insert of different size issued from a TTV isolate belonging to a different group. The assay was able to simultaneously amplify DNAs of TTV isolates belonging to all five phylogenetic groups. Multiplex PCR was then tested satisfactorily on DNAs extracted from 55 serum samples (47 health care workers and 8 AIDS patients). All individuals but nine were infected with at least one TTV isolate. Co-infection with multiple isolates was found in 29/47 (62%) health care workers and in 8/8 (100%) AIDS patients. A number of discrepancies were observed when results obtained with three thermostable DNA polymerases were compared. For example, four TTV phylogenetic groups were detected in a particular serum sample by using one of the three DNA polymerases, whereas the other two enzymes were able to detect only three TTV groups. However, none of the three enzymes used could be broadly considered to be more efficient than the others. Despite its limitations, the assay described here constitutes a suitable tool to visualize the degree of co-infection of a given population, avoiding time-consuming experiments.


Subject(s)
Acquired Immunodeficiency Syndrome/virology , DNA Virus Infections/virology , DNA, Viral/analysis , Phylogeny , Polymerase Chain Reaction/methods , Torque teno virus/genetics , Electrophoresis, Agar Gel , Humans , Male , Torque teno virus/isolation & purification
12.
Braz. j. med. biol. res ; 38(6): 853-860, June 2005. ilus, tab
Article in English | LILACS | ID: lil-402676

ABSTRACT

Torque teno virus (TTV) is a circular, single-stranded DNA virus that chronically infects healthy individuals of all ages worldwide. TTV has an extreme genetic heterogeneity which is reflected in its current classification into five main phylogenetic groups (1-5). Using specific PCR assays, it has been shown that many individuals are co-infected with TTV isolates belonging to different phylogenetic groups. Here, a multiplex PCR assay was developed, using five recombinant plasmids. Each plasmid carried an insert of different size issued from a TTV isolate belonging to a different group. The assay was able to simultaneously amplify DNAs of TTV isolates belonging to all five phylogenetic groups. Multiplex PCR was then tested satisfactorily on DNAs extracted from 55 serum samples (47 health care workers and 8 AIDS patients). All individuals but nine were infected with at least one TTV isolate. Co-infection with multiple isolates was found in 29/47 (62 percent) health care workers and in 8/8 (100 percent) AIDS patients. A number of discrepancies were observed when results obtained with three thermostable DNA polymerases were compared. For example, four TTV phylogenetic groups were detected in a particular serum sample by using one of the three DNA polymerases, whereas the other two enzymes were able to detect only three TTV groups. However, none of the three enzymes used could be broadly considered to be more efficient than the others. Despite its limitations, the assay described here constitutes a suitable tool to visualize the degree of co-infection of a given population, avoiding time-consuming experiments.


Subject(s)
Humans , Male , Acquired Immunodeficiency Syndrome/virology , DNA Virus Infections/virology , DNA, Viral/analysis , Phylogeny , Polymerase Chain Reaction/methods , Torque teno virus/genetics , Electrophoresis, Agar Gel , Torque teno virus/isolation & purification
14.
Arch Virol ; 149(7): 1383-95, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15221538

ABSTRACT

Hepatitis B virus (HBV) genotype A has been divided recently into two subgroups, designated A-A' (genotype A excluding A') and A'. Isolates belonging to subgroup A' have been identified in Africa. A new genotyping method, based on PCR amplification of the pre-S/S genome region and subsequent restriction fragment length polymorphism (RFLP) analysis, was developed, that established a correlation between RFLP subtypes and subgroups within genotype A. To investigate the occurrence of subgroup A' in South America, 119 Brazilian HBV isolates were analyzed. Ninety-three (78%) of them belonged to genotype A, with three predominating RFLP subtypes: 44 (37%) isolates were classified as AI, 30 (25%) were AII, and 18 (15%) were AIII. Pre-S/S nucleotide sequences of 15 genotype A isolates were determined. Phylogenetic analysis performed with these 15 and an additional 41 sequences revealed that isolates AI and AII clustered in subgroup A', whereas isolates AIII were classified into subgroup A-A'. The correlation RFLP subtypes-subgroups was confirmed by the presence of amino acid residues specific for subgroup A' in the surface antigens and polymerase of isolates AI and AII. The high proportion (63%) of isolates from subgroup A' suggested an African origin for a large number of Brazilian HBVs.


Subject(s)
Hepatitis B virus/classification , Hepatitis B virus/genetics , Hepatitis B/virology , Amino Acids/analysis , Brazil/epidemiology , DNA Fingerprinting , DNA, Viral/analysis , DNA, Viral/chemistry , DNA, Viral/isolation & purification , Genes, Viral , Genotype , Hepatitis B/epidemiology , Hepatitis B virus/isolation & purification , Humans , Molecular Epidemiology , Molecular Sequence Data , Phylogeny , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , Sequence Analysis, DNA , Viral Envelope Proteins/chemistry , Viral Envelope Proteins/genetics
15.
J Clin Virol ; 29(4): 254-9, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15018853

ABSTRACT

BACKGROUND: Hepatitis A virus (HAV) infection is the leading cause of clinically apparent viral hepatitis in many parts of the world, including developed and developing countries. Only limited information is available regarding the seronegative viremic window that follows HAV infection, and no systematic search has been reported for HAV RNA positive, IgM anti-HAV negative serum samples during hepatitis A outbreaks. OBJECTIVES: To determine the proportion of HAV infected individuals among (i) children who were tested negative for anti-HAV antibodies during hepatitis A outbreaks which occurred in a public school (n = 157) and a child care center (n = 38); (ii) subjects (n = 46) initially classified as acute non-A-C hepatitis patients after clinical examination and serological tests (sporadic cases). STUDY DESIGN: Reverse transcription (RT)-PCR was performed to detect the presence of HAV genome in serum samples collected from anti-HAV negative, susceptible subjects. RESULTS: HAV RNA was detected in 19/157 (12%) and 5/38 (13%) anti-HAV negative children from the public school and child care center, respectively. Twelve (26%) out of the 46 acute hepatitis patients (sporadic cases) were also HAV RNA positive. From nine of these 12 patients, a second blood sample was obtained 18-34 days after the first one: all nine had seroconverted to IgM anti-HAV, and their serum transaminases had reached elevated levels (mean ALT, 418; mean AST, 241). CONCLUSIONS: Detection of HAV RNA before IgM anti-HAV seroconversion may be used as an early diagnosis method during hepatitis A outbreaks. HAV RNA testing should also help to elucidate acute hepatitis cases of unknown etiology.


Subject(s)
Hepatitis A virus/isolation & purification , Hepatitis A/diagnosis , Hepatitis A/virology , RNA, Viral/blood , Adolescent , Adult , Child , Child Day Care Centers , Child, Preschool , Disease Outbreaks , Female , Hepatitis A/epidemiology , Hepatitis A Antibodies/blood , Hepatitis A virus/genetics , Humans , Immunoglobulin M/blood , Infant , Male , Middle Aged , Reverse Transcriptase Polymerase Chain Reaction , Schools , Transaminases/blood , Viremia
16.
J Pharmacol Exp Ther ; 309(2): 634-40, 2004 May.
Article in English | MEDLINE | ID: mdl-14742742

ABSTRACT

The potency, efficacy, and pharmacokinetic properties of IDN-6556 (3-[2-[(2-tert-butyl-phenylaminooxalyl)-amino]-propionylamino]-4-oxo-5-(2,3,5,6-tetrafluoro-phenoxy)-pentanoic acid), a first-in-class caspase inhibitor in clinical trials for the treatment of liver diseases, were characterized in vivo in rodent models. In the mouse alpha-Fas model of liver injury, i.p. administration of IDN-6556 resulted in marked reduction of alanine aminotransferase (ALT), apoptosis, and caspase activities at a dose of 3 mg/kg. At this dose, IDN-6556 was also effective when given up to 2 h before alpha-Fas and as late as 4 h after alpha-Fas administration. In both the alpha-Fas and d-galactosamine/lipopolysaccharide (D-Gln/LPS) model, ED(50) values in the sub-milligram per kilogram range were established after a number of routes of administration (i.p., i.v., i.m., or p.o.), ranging from 0.04 to 0.38 mg/kg. Efficacy was also demonstrated in the rat D-Gln/LPS model with 67 and 72% reductions in ALT activities after i.p. and p.o. treatment with IDN-6556 (10 mg/kg), respectively. Pharmacokinetic analysis in the rat demonstrated rapid clearance after i.v., i.p., and s.c. administration with terminal t(1/2) ranging from 46 to 51 min. Low absolute bioavailability after p.o. administration was seen (2.7-4%), but portal drug concentrations after oral administration were 3-fold higher than systemic concentrations with a 3.7-fold increase in the terminal t(1/2), indicating a significant first-pass effect. Liver concentrations remained constant after oral administration for at least a 4-h period, reaching a C(max) of 2558 ng/g liver at 120 min. Last, 51 +/- 20 and 4.9 +/- 3.4% of IDN-6556 was excreted intact in bile after i.v. and p.o. administration, respectively. This evaluation indicates that IDN-6556 has marked efficacy in models of liver disease after oral administration and thus, is an excellent candidate for the treatment of liver diseases characterized by excessive apoptosis.


Subject(s)
Caspase Inhibitors , Enzyme Inhibitors/pharmacokinetics , Pentanoic Acids/pharmacokinetics , Animals , Enzyme Inhibitors/blood , Enzyme Inhibitors/pharmacology , Male , Mice , Mice, Inbred BALB C , Models, Animal , Pentanoic Acids/blood , Pentanoic Acids/pharmacology , Rats , Rats, Sprague-Dawley
17.
J Infect ; 48(1): 102-8, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14667799

ABSTRACT

OBJECTIVE: To study the genomic variations of a hepatitis B virus (HBV) isolate in a patient coinfected with human immunodeficiency virus type 1 (HIV-1) who developed severe hepatitis and died of AIDS. METHODS: Two blood samples were collected, the first one during the asymptomatic phase of HIV-1 infection, and the other, 3 years later, few months before the death of the patient. Both samples were HBsAg and anti-HBe positive. Pre-S/S and precore-core genome regions were PCR amplified and analyzed. RESULTS: The HBV isolate belonged to genotype F, cluster IV. A number of unique amino acid substitutions were found in the surface antigen gene and the overlapping polymerase coding region of HBV genomes derived from both samples. However, these substitutions reflected natural variations rather than mutations of clinical significance. The precore stop codon mutation A(1896) was present in both genomes. Furthermore, the HBV genome derived from the second, but not first sample, showed two out-of-frame core interval deletions, one and 103 nucleotides in length, respectively. CONCLUSIONS: This is the first report of an HBV isolate from genotype F with core internal deletions. Our results suggest an association between specific core mutations and the severe hepatitis developed by the patient.


Subject(s)
AIDS-Related Opportunistic Infections/genetics , DNA Mutational Analysis , Hepatitis B virus/genetics , Hepatitis B, Chronic/virology , Adult , Fatal Outcome , Genome, Viral , Genotype , Hepatitis B virus/classification , Hepatitis B virus/isolation & purification , Humans , Male , Molecular Sequence Data , Phylogeny , Polymerase Chain Reaction
18.
Toxicol Sci ; 77(1): 172-82, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14600277

ABSTRACT

Monocrotaline (MCT) is a pyrrolizidine alkaloid (PA) plant toxin that produces sinusoidal endothelial cell (SEC) injury, hemorrhage, fibrin deposition, and coagulative hepatic parenchymal cell (HPC) oncosis in centrilobular regions of rat livers. Cells with apoptotic morphology have been observed in the livers of animals exposed to other PAs. Whether apoptosis occurs in the livers of MCT-treated animals and whether it is required for full manifestation of pathological changes is not known. To determine this, rats were treated with 300 mg MCT/kg, and apoptosis was detected by transmission electron microscopy and the TUNEL (TdT-mediated dUTP nick end labeling) assay. MCT produced significant apoptosis in the liver by 4 h after treatment. To determine if MCT kills cultured HPCs by apoptosis, HPCs were isolated from the livers of rats and exposed to MCT. MCT caused a concentration-dependent release of alanine aminotransferase (ALT), a marker of HPC injury. Furthermore, caspase 3 was activated and TUNEL staining increased in MCT-treated HPCs. MCT-induced TUNEL staining and release of ALT into the medium were completely prevented by the pancaspase inhibitors z-VAD.fmk and IDN-7314, suggesting that MCT kills cultured HPCs by apoptosis. To determine if caspase inhibition prevents MCT-induced apoptosis in the liver, rats were cotreated with MCT and IDN-7314. IDN-7314 reduced MCT-induced TUNEL staining in the liver and release of ALT into the plasma. Morphometric analysis confirmed that IDN-7314 reduced HPC oncosis in the liver by approximately 50%. Inasmuch as HPC hypoxia occurred in the livers of MCT-treated animals, upregulation of the hypoxia-regulated cell-death factor, BNIP3 (Bcl2/adenovirus EIB 19kD-interacting protein 3), was examined. BNIP3 was increased in the livers of mice treated 24 h earlier with MCT. Results from these studies show that MCT kills cultured HPCs by apoptosis but causes both oncosis and apoptosis in the liver in vivo. Furthermore, caspase inhibition reduces both apoptosis and HPC oncosis in the liver after MCT exposure.


Subject(s)
Apoptosis/drug effects , Hepatocytes/drug effects , Kupffer Cells/drug effects , Liver/drug effects , Monocrotaline/toxicity , Alanine Transaminase/metabolism , Animals , Caspase 3 , Caspase Inhibitors , Caspases/metabolism , Cells, Cultured , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Hepatocytes/enzymology , Hepatocytes/ultrastructure , In Situ Nick-End Labeling , Kupffer Cells/enzymology , Kupffer Cells/ultrastructure , Liver/enzymology , Liver/pathology , Male , Mice , Mice, Inbred C57BL , Microscopy, Electron , Monocrotaline/administration & dosage , Monocrotaline/metabolism , Rats , Rats, Sprague-Dawley
19.
J Infect ; 47(2): 125-8, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12860145

ABSTRACT

OBJECTIVE: HAV infection in patients with pre-existing chronic liver disease has been associated with increased rate of fulminant hepatitis and mortality. The aim of this study was to investigate the presence of serological and molecular HAV markers in a population of HCV infected patients. PATIENTS AND METHODS: The presence of total and IgM anti-HAV antibodies was investigated in 197 patients (mean age 44.8+/-12.5 years) referred to the Brazilian Reference Center for Viral Hepatitis and who tested positive for anti-HCV antibodies and HCV RNA. HAV RNA was investigated by reverse transcription-nested PCR in these patients.Results. One hundred seventy patients (86%) had total, but not IgM anti-HAV antibodies, being therefore, immune to hepatitis A, while 27 (14%) were not. A high proportion (6/27, 22%) of the susceptible patients presented markers of recent HAV infection: One patient was IgM anti-HAV positive, three were HAV RNA positive, and two presented both markers. By nucleotide sequencing, it was demonstrated that the HAV isolates infecting these patients belonged to subgenotypes 1A and 1B. CONCLUSIONS: Superinfection with HAV was a common event in the group of HCV infected patients under study. Implementation of hepatitis A vaccination should be considered for this population.


Subject(s)
Hepatitis A/complications , Hepatitis A/epidemiology , Hepatitis C/complications , Hepatitis C/epidemiology , Adult , Brazil/epidemiology , Female , Hepatitis A/genetics , Hepatitis A Antibodies/blood , Hepatitis C/genetics , Humans , Immunoglobulin M/blood , Male , Middle Aged , RNA, Viral/blood , Reverse Transcriptase Polymerase Chain Reaction
20.
Arch Virol ; 148(3): 517-29, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12607102

ABSTRACT

Isolates of the newly characterized, single-stranded DNA virus TTV, have been tentatively classified into four major phylogenetic groups and at least 28 genotypes. Four Japanese isolates, designated as YONBAN viruses, belong to the fourth group and to genotype 21. In this study, a genotype 21-specific PCR assay was standardized. With this assay, 48/184 (26%) serum samples and 76/167 (46%) saliva samples, collected from unselected ambulatory patients (aged 2 to 82) of a Brazilian public hospital, were positive. A total of 110 (66%) patients had TTV genotype 21 DNA in serum, saliva, or both fluids. Furthermore, 18/37 (49%) serum samples, collected from Indians belonging to three ethnic groups of the Western Brazilian Amazon, were also positive. Nucleotide sequences (253 bases at the 3' end of the non-coding region of the genome) were determined, that derived from 25 individuals, i.e. 17 patients and eight Indians. Phylogenetic analysis showed that three isolates from Indians of a particular ethnic group formed a separate subgroup within genotype 21. Among non-Indians, a clustering of strains was observed according to their country of origin (Japan or Brazil), with all 17 sequences derived from Brazilian patients located in a unique subgroup.


Subject(s)
DNA Virus Infections/epidemiology , Genetic Variation , Torque teno virus/classification , Torque teno virus/isolation & purification , Adolescent , Adult , Aged , Aged, 80 and over , Ambulatory Care , Brazil/epidemiology , Child , Child, Preschool , DNA Virus Infections/ethnology , DNA Virus Infections/virology , DNA, Viral/analysis , Female , Genotype , Hospitals, University , Humans , Indians, South American , Male , Middle Aged , Molecular Sequence Data , Phylogeny , Prevalence , Sequence Analysis, DNA , Torque teno virus/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...